Search

Now showing items 1-1 of 1

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.

Asselah, T; Moreno, C; Sarrazin, C; Gschwantler, M; Foster, GR; Craxí, A; Buggisch, P; Sanai, F; Bicer, C; Lenz, O;... (2017)

BACKGROUND: HCV GT4 accounts for up to 20% of HCV infections worldwide. Simeprevir, given for 12 weeks as part of a 24- or 48-week combination regimen with PR is approved for the treatment of chronic HCV GT4 infection. ...